Researchers conducted the largest observational study of minimally invasive transfemoral—entry through the groin—TAVR to find whether the use of moderate sedation is associated with improved patient outcomes, specifically evaluating 30-day mortality and length of hospital stays, as compared to traditional general anesthesia.